MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 199 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.76 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,788,413 | +70.5% | 11,510 | +104.2% | 0.78% | +85.5% |
| Q4 2022 | $1,635,849 | +128.8% | 5,636 | +68.7% | 0.42% | +45.5% |
| Q3 2018 | $715,000 | -49.3% | 3,340 | -33.8% | 0.29% | -57.9% |
| Q2 2018 | $1,411,000 | +49.2% | 5,046 | -37.7% | 0.69% | +40.6% |
| Q1 2018 | $946,000 | – | 8,100 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 1,402,250 | $93,614,000 | 4.00% |
| Parkman Healthcare Partners LLC | 30,000 | $2,003,000 | 0.93% |
| ARMISTICE CAPITAL, LLC | 216,000 | $14,420,000 | 0.89% |
| Avoro Capital Advisors LLC | 349,000 | $23,299,000 | 0.79% |
| Rock Springs Capital Management LP | 250,000 | $16,690,000 | 0.69% |
| Capital Impact Advisors, LLC | 24,351 | $1,626,000 | 0.68% |
| Baker Brothers Advisors | 1,499,212 | $100,087,000 | 0.62% |
| EWG Elevate Inc. | 11,086 | $740,000 | 0.56% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $801,000 | 0.54% |
| DAFNA Capital Management LLC | 13,600 | $908,000 | 0.38% |